SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001521536-12-000694
Filing Date
2012-07-31
Accepted
2012-07-30 18:27:44
Documents
20
Period of Report
2012-01-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1100643_8ka-biozone.htm 8-K/A 24121
2 PERSONAL GUARANTY OF DANIEL FISHER AND BRIAN KELLER DATED AUGUST 23, 2011 q1100643_ex10-1.htm EX-10.1 2262
3 LETTER FROM DANIEL FISHER q1100643_ex17-1.htm EX-17.1 13331
4 GRAPHIC ex10-1_page001.jpg GRAPHIC 370828
5 GRAPHIC ex10-1_page002.jpg GRAPHIC 274520
6 GRAPHIC ex17-1_page001.jpg GRAPHIC 236589
7 GRAPHIC ex17-1_page002.jpg GRAPHIC 91098
8 GRAPHIC ex17-1_page003.jpg GRAPHIC 285426
9 GRAPHIC ex17-1_page004.jpg GRAPHIC 284637
10 GRAPHIC ex17-1_page005.jpg GRAPHIC 282422
11 GRAPHIC ex17-1_page006.jpg GRAPHIC 292778
12 GRAPHIC ex17-1_page007.jpg GRAPHIC 345658
13 GRAPHIC ex17-1_page008.jpg GRAPHIC 367545
14 GRAPHIC ex17-1_page009.jpg GRAPHIC 383619
15 GRAPHIC ex17-1_page010.jpg GRAPHIC 291599
16 GRAPHIC ex17-1_page011.jpg GRAPHIC 244225
17 GRAPHIC ex17-1_page012.jpg GRAPHIC 331954
18 GRAPHIC ex17-1_page013.jpg GRAPHIC 386369
19 GRAPHIC ex17-1_page014.jpg GRAPHIC 382299
20 GRAPHIC ex17-1_page015.jpg GRAPHIC 27510
  Complete submission text file 0001521536-12-000694.txt   6765756
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-146182 | Film No.: 12994794
SIC: 2834 Pharmaceutical Preparations